SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor

Massachusetts General Hospital at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

Massachusetts General Hospital brings 18 presentations to SITC 2026 in Phoenix. Its program centres on the side effects of immune checkpoint drugs, from hepatitis and arthritis to skin reactions, and on CAR T cells for solid tumors. One distinctive item asks whether these side effects rise and fall with the seasons.

OrganizationSITC 2026 Attendance
Cancer centres & hospitals
Harvard teaching hospital in Boston and home of the Mass General Cancer Center.
Poster
Fri Nov 6
12:15–1:45pm
5:30–7pm
Session
Fri Nov 6
1:45pm–3:25pm
Mechanisms of irAEs
Clinical
  1. 1:50pm–2:10pmDiet and Microbiome Drivers of Immune Related Adverse EventsUniversity of Pittsburgh
  2. 2:10pm–2:30pmUnlocking the Specificity of the Autoimmune Response in iRAE’sUCSF
  3. 2:30pm–2:50pmClinical Trials for irAEs: Where Do We Go Next?Vanderbilt University Medical Center
  4. 2:50pm–3:05pmIL-27 is a critical mediator of ICI response and irAEsHuntsman Cancer Institute
  5. 3:05pm–3:20pmIL-12/23 Inhibition Mitigates Immune Checkpoint Blockade-derived Immune-related Adverse Events While Maintaining Anti-Tumor Efficacy in Preclinical Models.Johnson & Johnson
Session
Sat Nov 7
3:30pm–4:50pm
IO in Low Mutation Burden Cancers
Tumor biology
  1. 3:35pm–3:55pmCombining Targeted and Immunotherapy in pMMR Colorectal CancerJohns Hopkins University
  2. 3:55pm–4:15pmFrom the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint TherapyMD Anderson Cancer Center
  3. 4:15pm–4:35pmBeyond the Canonical Proteome: Identifying Immunogenic Targets in Ovarian TumorsMayo Clinic
  4. 4:35pm–4:50pmAdaptive anti-CAR immunity compromises the durability of GD2-CAR T cell therapy in diffuse midline gliomaStanford Cancer Institute
Talk
Sat Nov 7
4:10pm–4:30pm
LILRB Checkpoints
Tumor biology · New agents
Session
Sat Nov 7
3:30pm–4:50pm
Microbiome and Metabolism
Tumor biology
  1. 3:30pm–3:45pmCorrecting the Gut Microbiome Dysbiosis in OncologyCentre hospitalier de l'Université de Montréal (CHUM)
  2. 3:45pm–4:00pmToward Metabotherapy for CancerStanford University
  3. 4:00pm–4:15pmIntratumoral Bacterial Elements in Brain TumorsMoffitt Cancer Center
  4. 4:15pm–4:25pmGut Microbiota Metabolite Control of Antitumor CD8 T Cell TraffickingMassachusetts General Hospital
  5. 4:25pm–4:35pmGut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in MelanomaUniversity of Pittsburgh
Talk
Sat Nov 7
5:40pm–5:55pm

Explore the full SITC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Phoenix. Leave your work email and we’ll be in touch.

Privacy

Download the full SITC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Massachusetts General Hospital

Tell us what you sell and we’ll find the people at Massachusetts General Hospital most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction